Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

Dr. Rituraj Upadhyay | Healthcare Data Analysis | Best Researcher Award

The Ohio State University, United States

Author Profiles

Orcid

Google Scholar

Research Gate

Early Academic Pursuits 🎓

Dr. Rituraj Upadhyay began his academic journey with a strong foundation in medical education at the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi. There, he completed his Bachelor of Medicine and Surgery (MBBS) in 2014, followed by an MD in Radiation Oncology (2017). His early medical training was marked by a deep interest in radiotherapy and oncology, leading him to pursue a Diplomate of National Board (DNB) certification in Radiation Oncology. His academic endeavors during this time reflected a commitment to advancing medical knowledge and improving patient care through radiation oncology.

Professional Endeavors 🌍

Dr. Upadhyay’s professional career has been driven by a passion for advancing radiation oncology, particularly through his work in clinical and academic settings. His residency at The Ohio State University Wexner Medical Center (2021–2025) is a notable highlight in his professional journey, demonstrating his commitment to mastering the latest technologies and treatments in radiation oncology. Dr. Upadhyay’s time at renowned institutions like MD Anderson Cancer Center and Rutgers Cancer Institute of New Jersey has further solidified his standing as an emerging leader in the field. His pursuit of innovation and excellence is evident from his involvement in advanced radiation oncology fellowships and international research collaborations.

Contributions and Research Focus 🔬

Dr. Upadhyay’s research is at the forefront of radiation oncology, with a focus on improving treatment outcomes and minimizing side effects. He has contributed significantly to clinical trials and funded research, such as the “PRIMe-STAR trial” on progressive/recurrent intracranial meningiomas and the “AVATAR” system aimed at reducing anesthesia needs in pediatric radiotherapy. His research on stereotactic radiosurgery for brain metastases and radiation therapy for conditions like penile cancer and renal stereotactic ablative therapy underscores his diverse interests in cancer treatment. His studies have potential global impact, as reflected in his leadership role in multinational research endeavors.

Impact and Influence 🌟

Dr. Upadhyay’s influence extends beyond his research. As an educator and mentor, he actively shapes the next generation of radiation oncologists. His roles in mentoring medical students, residents, and fellows at institutions like The Ohio State University and Massachusetts General Hospital highlight his dedication to guiding aspiring professionals. He also plays a key role in enhancing the field through his involvement in various professional organizations such as the American Society for Radiation Oncology (ASTRO) and the Radiosurgery Society (RSS). His work as a guideline reviewer and committee member for several radiation oncology societies reflects his broad influence on the development of standards and best practices in the field.

Academic Cites 📚

Dr. Upadhyay’s research and academic work are well-regarded, with his contributions earning recognition through numerous awards and honors. Notable accolades include the American College of Radiation Oncology (ACRO) Best Abstract Award and the American Radium Society (ARS) Early Career Oncologist Award, which are testaments to his influential research on topics like stereotactic radiosurgery and palliative radiation therapy. These accolades further cement his reputation in the academic community, demonstrating the high regard in which his peers hold his research.

Technical Skills 💻

Dr. Upadhyay has developed a comprehensive set of technical skills that position him at the cutting edge of radiation oncology. His expertise spans advanced radiation therapy techniques such as stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), proton therapy, and image-guided brachytherapy. In addition, he is well-versed in cutting-edge technologies, including the use of artificial intelligence and machine learning in radiation oncology for treatment planning and quality assurance. His technical acumen is further demonstrated by his involvement in developing new approaches to enhance clinical outcomes for complex cancer cases.

Teaching Experience 📖

Dr. Upadhyay has dedicated substantial time to teaching and mentorship, sharing his expertise with medical students, residents, and fellow researchers. He has served as a moderator for educational webinars and a mentor for various research initiatives. His roles as a panelist and speaker at international conferences, such as the ASTRO Annual Meeting and the Ohio State University Cardio-Oncology Symposium, reflect his commitment to advancing education within the field of oncology. Through these initiatives, he has played a key role in shaping the future of radiation oncology education.

Legacy and Future Contributions 🔮

Dr. Upadhyay’s legacy in radiation oncology is already being established through his groundbreaking research and mentorship. His involvement in international clinical trials, such as the AVATAR system and the PRIMe-STAR trial, is likely to make a long-lasting impact on the clinical management of cancer patients globally. Looking forward, Dr. Upadhyay plans to continue advancing his research, particularly in the areas of stereotactic radiosurgery and precision medicine. His work promises to significantly shape the future of radiation oncology, particularly in improving treatment efficacy, minimizing side effects, and enhancing patient care across diverse populations.

 

Top Noted Publications 📖

Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas

Authors: Divya Yadav, Rituraj Upadhyay, Vinodh A. Kumar, Melissa M. Chen, Jason M. Johnson, Holly Langshaw, Brandon J. Curl, Maguy Farhat, Wasif Talpur, Thomas H. Beckham et al.

Journal: Practical Radiation Oncology

Year: 2024

Risk-Stratified Radiotherapy in Pediatric Cancer

Authors: Rituraj Upadhyay, Arnold C. Paulino

Journal: Cancers

Year: 2024

Disease Control and Toxicity Outcomes after Stereotactic Ablative Radiation Therapy for Recurrent and/or Metastatic Cancers in Young-Adult and Pediatric Patients

Authors: Rituraj Upadhyay, Brett Klamer, Jennifer Matsui, Vikram B. Chakravarthy, Thomas Scharschmidt, Nicholas Yeager, Bhuvana A. Setty, Timothy P. Cripe, Ryan D. Roberts, Jennifer H. Aldrink et al.

Journal: Cancers

Year: 2024

Quantifying the Risk and Dosimetric Variables of Symptomatic Brainstem Injury after Proton Beam Radiation in Pediatric Brain Tumors

Authors: Rituraj Upadhyay, Kaiping Liao, David R Grosshans, Susan L McGovern, Mary Frances McAleer, Wafik Zaky, Murali M Chintagumpala, Anita Mahajan, Debra Nana Yeboa, Arnold C Paulino

Journal: Neuro-Oncology

Year: 2022

Patterns of Failure after Radiation Therapy in Primary Spinal High-Grade Gliomas: A Single Institutional Analysis

Authors: Rituraj Upadhyay, Swapnil Khose, Halyna Pokhylevych, Arnold C Paulino, Mary Frances McAleer, Amol Ghia, Jing Li, Debra Nana Yeboa, Monica Loghin, Rebecca Harrison et al.

Journal: Neuro-Oncology Advances

Year: 2022

Hao Gao | Healthcare Data Analysis | Best Researcher Award

Prof. Hao Gao | Healthcare Data Analysis | Best Researcher Award

Jinan University, China

Author Profiles

orcid

Scopus

Research Gate

👨‍🎓 Early Academic Pursuits

Prof. Hao Gao began his academic journey with a strong foundation in natural medicine chemistry. He received his PhD from Shenyang Pharmaceutical University in 2005, focusing on the chemistry of natural medicines. This early academic work set the stage for his future contributions to the field of Traditional Chinese Medicine (TCM). After completing his doctorate, he further honed his expertise through postdoctoral training at Tsinghua University (2006-2008), a renowned institution that significantly influenced his approach to scientific research and innovation.

💼 Professional Endeavors and Leadership

Prof. Gao’s professional trajectory has been marked by leadership roles that have shaped his career and the direction of his research. In 2008, he joined the Institute of Traditional Chinese Medicine & Natural Products at Jinan University as a faculty member. Since 2013, he has been a professor at the university and, in 2016, assumed the position of Head of the Institute of Traditional Chinese Medicine & Natural Products. In 2020, he expanded his administrative responsibilities by taking on the role of Director of the Science and Technology Department at Jinan University. Prof. Gao’s leadership has been pivotal in fostering multidisciplinary collaborations and advancing research initiatives in natural medicine chemistry.

🔬 Contributions and Research Focus

Prof. Gao’s research is primarily centered on natural medicine chemistry, with a particular focus on the active compounds and technological advancements related to Traditional Chinese Medicine (TCM). His work is dedicated to exploring under-researched medicinal materials like Lycium barbarum, Angelica sinensis, and Ophiocordyceps sinensis, which are central to TCM practices. Prof. Gao has made significant strides in identifying bioactive substances and developing novel drugs derived from TCM. Notably, his research has led to the discovery of four classes of lead compounds for anti-dementia drugs, all characterized by independent intellectual property rights.

🌍 Impact and Influence

Prof. Gao’s impact extends beyond academia, with substantial contributions to the modernization of TCM and drug development. His collaborations with international experts, such as Professor Ikuro Abe from the University of Tokyo, have facilitated the establishment of the International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development, a joint initiative between China’s Ministry of Education and Jinan University. This partnership exemplifies Prof. Gao’s influence on global TCM research and highlights his role in pushing the boundaries of natural product-based drug development.

📚 Academic Citations and Recognition

Prof. Gao’s research has gained widespread recognition, reflected in his 4100 citations across various SCI journals. His work has significantly contributed to the advancement of natural medicine chemistry and TCM, making him a highly influential figure in the field. His numerous publications, with 195 journal articles and one book published, continue to shape research in TCM and pharmacology. Moreover, his leadership as an editor for the China Section of the Journal of Natural Medicines and as an editorial board member for Acta Pharmaceutica Sinica B highlights his prominence in the academic community.

🛠️ Technical Skills and Innovations

Prof. Gao’s technical expertise spans various critical areas, including the extraction, isolation, and characterization of bioactive compounds from TCM. His innovations in pharmacodynamic constituents of TCM have contributed to the discovery of novel drug candidates, some of which are in the process of patenting. With over 71 patents published or pending, Prof. Gao stands at the forefront of translating TCM practices into scientifically validated therapeutic solutions. His lab continues to focus on critical technologies that aim to enhance the efficacy and safety of TCM-derived medicines.

👩‍🏫 Teaching Experience

In addition to his research, Prof. Gao has been an integral part of the academic community at Jinan University, mentoring and guiding students in the fields of pharmacology and natural medicine chemistry. His teaching philosophy integrates cutting-edge research with practical applications in TCM, ensuring that his students are well-equipped to pursue careers in both academia and industry. As a mentor, Prof. Gao has inspired numerous graduate students and postdoctoral researchers, many of whom have gone on to make their own contributions to TCM and drug development.

🌱 Legacy and Future Contributions

Prof. Gao’s legacy is built on his pioneering work in natural medicine chemistry and the modernization of Traditional Chinese Medicine. His research continues to influence the field, with ongoing projects that promise to uncover more bioactive compounds and therapeutic agents. As his career progresses, Prof. Gao remains committed to advancing TCM through innovation and interdisciplinary collaboration. His future work will likely expand the global recognition of TCM-based drugs, pushing the boundaries of natural product drug discovery and pharmacology for the betterment of human health.

🌟 Professional Memberships and Editorial Roles

Prof. Gao is an active member of the China Association of Chinese Medicine, where he serves as Vice Chairperson of the Youth Work Committee. His role in professional societies and editorial boards, including his editorial positions in high-impact journals, underscores his authority in the fields of natural products and biosynthesis. His leadership extends to guiding the next generation of researchers and practitioners in these fields.

📖 Top Noted Publications 

Functional and structural dissection of glycosyltransferases underlying the glycodiversity of wolfberry-derived bioactive ingredients lycibarbarspermidines
    • Authors: Li, S.-Y., Wang, G.-Q., Long, L., Abe, I., Gao, H.
    • Journal: Nature Communications
    • Year: 2024
Identification of three novel P450 enzymes involved in the oxidative modification of a newly discovered fusicoccane diterpene
    • Authors: Dong, L., Liu, J.-Y., Wang, G.-Q., Hu, D., Gao, H.
    • Journal: Bioorganic Chemistry
    • Year: 2024
Targeted Discovery of a Natural ortho-Quinone Methide Precursor and Green Generation of Its Oligomers
    • Authors: Wang, X.-X., Deng, B.-Q., Ouyang, Z.-Q., Yao, X.-S., Gao, H.
    • Journal: Journal of Natural Products
    • Year: 2024
A Functional Switch Between Asperfumene and Fusicoccadiene Synthase and Entrance to Asperfumene Biosynthesis through a Vicinal Deprotonation-Reprotonation Process
    • Authors: Liu, J.-Y., Lin, F.-L., Taizoumbe, K.A., Gao, H., Dickschat, J.S.
    • Journal: Angewandte Chemie – International Edition
    • Year: 2024
Mechanistic characterisation of a fungal fusicoccane-type diterpene synthase involved in the biosynthesis of talaro-7,13-diene
    • Authors: Lin, F.-L., Taizoumbe, K.A., Wang, Y.-X., Gao, H., Dickschat, J.S.
    • Journal: Organic and Biomolecular Chemistry
    • Year: 2024